Clinical Trials Browser

Phase NA × eribulin × Clear all

NCT02841722 2020-06-24

EMEG-E-01

Phase NA Completed

Breast Neoplasms

NCT01142661 2013-09-20

Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies

Phase NA Completed

9 enrolled 8 charts

Breast Neoplasms